Journal Articles

2021

Zhang, Q., Schultz, J. L., Aldridge, G. M., Simmering, J. E., Kim, Y., Ogilvie, A. C., & Narayanan, N. S. (2021). COVID-19 Case Fatality and Alzheimer's Disease. Journal of Alzheimer's disease : JAD, 10.3233/JAD-215161. Advance online publication. https://doi.org/10.3233/JAD-215161 PMID: 34690147

Ogilvie, A. C., Nopoulos, P. C., & Schultz, J. L. (2021). Quantifying the Onset of Unintended Weight Loss in Huntington's Disease: A Retrospective Analysis of Enroll-HD. Journal of Huntington's disease, 10.3233/JHD-210488. Advance online publication. https://doi.org/10.3233/JHD-210488 PMID: 34633327

Ogilvie, A. C., Nopoulos, P. C., & Schultz, J. L. (2021). Sleep disturbances by disease type and stage in Huntington's disease. Parkinsonism & related disorders, 91, 13–18. Advance online publication. https://doi.org/10.1016/j.parkreldis.2021.08.011 PMID: 34450461

van der Plas, E., Lullmann, O., Hopkins, L., Schultz, J. L., Nopoulos, P. C., & Harshman, L. A. (2021). Associations between neurofilament light-chain protein, brain structure, and chronic kidney disease. Pediatric research, 10.1038/s41390-021-01649-6. Advance online publication. https://doi.org/10.1038/s41390-021-01649-6 PMID: 34274959

Schultz, J. L., Saft, C., & Nopoulos, P. C. (2021). Association of CAG Repeat Length in the Huntington Gene With Cognitive Performance in Young Adults. Neurology, 96(19), e2407–e2413. https://doi.org/10.1212/WNL.0000000000011823 PMID: 33692166

Schultz, J. L., Harshman, L. A., Kamholz, J. A., & Nopoulos, P. C. (2021). Autonomic dysregulation as an early pathologic feature of Huntington Disease. Autonomic neuroscience : basic & clinical, 231, 102775. https://doi.org/10.1016/j.autneu.2021.102775 PMID: 33571915

Schultz, J. L., van der Plas, E., Langbehn, D. R., Conrad, A. L., & Nopoulos, P. C. (2021). Age-Related Cognitive Changes as a Function of CAG Repeat in Child and Adolescent Carriers of Mutant Huntingtin. Annals of neurology, 89(5), 1036–1040. https://doi.org/10.1002/ana.26039 PMID: 33521985

Bald, E. M., Nance, C. S., & Schultz, J. L. (2021). Melatonin may slow disease progression in amyotrophic lateral sclerosis: Findings from the Pooled Resource Open-Access ALS Clinic Trials database. Muscle & nerve, 63(4), 572–576. https://doi.org/10.1002/mus.27168 PMID: 33428242

Ogilvie, A. C., Gonzalez-Alegre, P., & Schultz, J. L. (2021). Diabetes Mellitus Is Associated With an Earlier Age of Onset of Huntington's Disease. Movement disorders : official journal of the Movement Disorder Society, 36(4), 1033–1034. https://doi.org/10.1002/mds.28460 PMID: 33368647

Solomon, M. A., van der Plas, E., Langbehn, K. E., Novak, M., Schultz, J. L., Koscik, T. R., Conrad, A. L., Brophy, P. D., Furth, S. L., Nopoulos, P. C., & Harshman, L. A. (2021). Early pediatric chronic kidney disease is associated with brain volumetric gray matter abnormalities. Pediatric research, 89(3), 526–532. https://doi.org/10.1038/s41390-020-01203-w PMID: 33069166

2020

Zhang, Q., Schultz, J. L., Aldridge, G. M., Simmering, J. E., & Narayanan, N. S. (2020). Coronavirus Disease 2019 Case Fatality and Parkinson's Disease. Movement disorders : official journal of the Movement Disorder Society, 35(11), 1914–1915. https://doi.org/10.1002/mds.28325 PMID: 32954522

van der Plas, E., Schultz, J. L., & Nopoulos, P. C. (2020). The Neurodevelopmental Hypothesis of Huntington's Disease. Journal of Huntington's disease, 9(3), 217–229. https://doi.org/10.3233/JHD-200394 PMID: 32925079

Schultz, J. L., & Nopoulos, P. C. (2020). Autonomic Changes in Juvenile-Onset Huntington's Disease. Brain sciences, 10(9), 589. https://doi.org/10.3390/brainsci10090589 PMID: 32858858

Schultz, J. L., Moser, A. D., & Nopoulos, P. C. (2020). The Association between CAG Repeat Length and Age of Onset of Juvenile-Onset Huntington's Disease. Brain sciences, 10(9), 575. https://doi.org/10.3390/brainsci10090575 PMID: 32825467

Tereshchenko, A. V., Schultz, J. L., Kunnath, A. J., Bruss, J. E., Epping, E. A., Magnotta, V. A., & Nopoulos, P. C. (2020). Subcortical T1-Rho MRI Abnormalities in Juvenile-Onset Huntington's Disease. Brain sciences, 10(8), 533. https://doi.org/10.3390/brainsci10080533 PMID: 32784364

Schultz, J. L., Harshman, L. A., Langbehn, D. R., & Nopoulos, P. C. (2020). Hypertension Is Associated With an Earlier Age of Onset of Huntington's Disease. Movement disorders : official journal of the Movement Disorder Society, 35(9), 1558–1564. https://doi.org/10.1002/mds.28062 PMID: 32339315 

Tereshchenko, A. V., Schultz, J. L., Bruss, J. E., Magnotta, V. A., Epping, E. A., & Nopoulos, P. C. (2020). Abnormal development of cerebellar-striatal circuitry in Huntington disease. Neurology, 94(18), e1908–e1915. https://doi.org/10.1212/WNL.0000000000009364 PMID: 32265233

2019

Cai, R., Zhang, Y., Simmering, J. E., Schultz, J. L., Li, Y., Fernandez-Carasa, I., Consiglio, A., Raya, A., Polgreen, P. M., Narayanan, N. S., Yuan, Y., Chen, Z., Su, W., Han, Y., Zhao, C., Gao, L., Ji, X., Welsh, M. J., & Liu, L. (2019). Enhancing glycolysis attenuates Parkinson's disease progression in models and clinical databases. The Journal of clinical investigation, 129(10), 4539–4549. https://doi.org/10.1172/JCI129987 PMID: 31524631

Wright, B. A., Singh, S. B., Schultz, J. L., Ramsey, L. J., Spading, K. A., Mascardo, L. A., & Starner, T. D. (2019). Impact of pharmacy services on cystic fibrosis transmembrane conductance regulator modulator prescribing at a pediatric cystic fibrosis center. Pediatric pulmonology, 54(10), 1591–1595. https://doi.org/10.1002/ppul.24446 PMID: 31294925

Schultz, J. L., Nopoulos, P. C., Killoran, A., Ogilvie, A., & Kamholz, J. A. (2019). Author response to Dr. Aziz-"Statin use and delayed onset of Huntington disease". Movement disorders : official journal of the Movement Disorder Society, 34(5), 763–764. https://doi.org/10.1002/mds.27678 PMID: 31091359

Schultz, J. L., Killoran, A., Nopoulos, P. C., Moser, D. J., & Kamholz, J. A. (2019). Author response: Evaluating depression and suicidality in tetrabenazine users with Huntington disease. Neurology, 92(9), 448. https://doi.org/10.1212/WNL.0000000000007000 PMID: 30804062

Schultz J. L. (2019). Author response: Evaluating depression and suicidality in tetrabenazine users with Huntington disease. Neurology, 92(9), 447. https://doi.org/10.1212/WNL.0000000000006998 PMID: 30804060

Schultz, J. L., Nopoulos, P. C., Killoran, A., & Kamholz, J. A. (2019). Statin use and delayed onset of Huntington's disease. Movement disorders : official journal of the Movement Disorder Society, 34(2), 281–285. https://doi.org/10.1002/mds.27591 PMID: 30576007

2018

Schultz, J. L., Kamholz, J. A., Nopoulos, P. C., & Killoran, A. (2018). Comparing Risperidone and Olanzapine to Tetrabenazine for the Management of Chorea in Huntington Disease: An Analysis from the Enroll-HD Database. Movement disorders clinical practice, 6(2), 132–138. https://doi.org/10.1002/mdc3.12706 PMID: 30838312

Schultz J. (2018). Disease-modifying treatment of amyotrophic lateral sclerosis. The American journal of managed care, 24(15 Suppl), S327–S335. PMID: 30207671

Schultz, J. L., Killoran, A., Nopoulos, P. C., Chabal, C. C., Moser, D. J., & Kamholz, J. A. (2018). Evaluating depression and suicidality in tetrabenazine users with Huntington disease. Neurology, 91(3), e202–e207. https://doi.org/10.1212/WNL.0000000000005817 PMID: 29925548

Schultz, J. L., Nopoulos, P. C., & Gonzalez-Alegre, P. (2018). Human Immunodeficiency Virus Infection in Huntington's Disease is Associated with an Earlier Age of Symptom Onset. Journal of Huntington's disease, 7(2), 163–166. https://doi.org/10.3233/JHD-180287 PMID: 29843248

Schultz, J. L., Horner, K. E., McDanel, D. L., Miller, M. L., Beranek, R. L., Jacobsen, R. B., Sly, N. J., Miller, A. C., & Mascardo, L. A. (2018). Comparing Clinical Outcomes of a Pharmacist-Managed Diabetes Clinic to Usual Physician-Based Care. Journal of pharmacy practice, 31(3), 268–271. https://doi.org/10.1177/0897190017710522 PMID: 28532224

2017

Schultz, J. L., Kamholz, J. A., Moser, D. J., Feely, S. M., Paulsen, J. S., & Nopoulos, P. C. (2017). Substance abuse may hasten motor onset of Huntington disease: Evaluating the Enroll-HD database. Neurology, 88(9), 909–915. https://doi.org/10.1212/WNL.0000000000003661 PMID: 28148631 

2016

Schultz, J., Weber, C., & Kamholz, J. (2016). Letter to the Editor: The Emerging Role of Pharmacists in the Multidisciplinary Care of Patients with Multiple Sclerosis. International journal of MS care, 18(5), 219–220. https://doi.org/10.7224/1537-2073.2015-079 PMID: 27803636

Schultz, J., Bream-Rouwenhorst, H., Hobbs, R., McDanel, D., & Goerbig-Campbell, J. (2016). Serotonergic agents increase the incidence of gastrointestinal bleeds in patients with continuous-flow left ventricular assist devices. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 35(6), 823–824. https://doi.org/10.1016/j.healun.2015.12.025 PMID: 26944672

Schultz J. L. (2016). Implementation and Clinical Outcomes of an Employer-Sponsored, Pharmacist-Provided Medication Therapy Management Program--Alternative Viewpoint. Pharmacotherapy, 36(3), e15. https://doi.org/10.1002/phar.1724 PMID: 26888553